Clinical Trial Update: Palbociclib and Binimetinib in Advanced Triple Negative Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

This document reports the results of a Phase 1/2 clinical trial evaluating the combination of palbociclib and binimetinib in patients with advanced triple-negat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Binimetinib (binimetinib)
• Palbociclib (palbociclib)

Snippet

Sponsor: Fundacion Oncosur | Conditions: Triple Negative Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-03-24